000 01350 a2200385 4500
005 20250517071159.0
264 0 _c20160706
008 201607s 0 0 eng d
022 _a1471-2458
024 7 _a10.1186/s12889-015-2596-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerguson, Stuart G
245 0 0 _aExamination of the mechanism of action of two pre-quit pharmacotherapies for smoking cessation.
_h[electronic resource]
260 _bBMC public health
_cDec 2015
300 _a1268 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAffect
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNicotinic Agonists
_xadministration & dosage
650 0 4 _aResearch Design
650 0 4 _aSmartphone
650 0 4 _aSmoking Cessation
_xmethods
650 0 4 _aSocial Environment
650 0 4 _aSubstance Withdrawal Syndrome
_xepidemiology
650 0 4 _aTobacco Use Cessation Devices
650 0 4 _aVarenicline
_xadministration & dosage
700 1 _aWalters, Julia A E
700 1 _aLu, Wenying
700 1 _aWells, Gudrun P
700 1 _aSchüz, Natalie
773 0 _tBMC public health
_gvol. 15
_gp. 1268
856 4 0 _uhttps://doi.org/10.1186/s12889-015-2596-2
_zAvailable from publisher's website
999 _c25561781
_d25561781